InsidersTradesSigma
Explore the complete record of transactions filed by Alkaben Dipakkumar Shah. Director active across 1 company, notably Remus Pharmaceuticals Limited. In total, 1 disclosures have been published. Activity tracked since 2 January 2026. The latest transaction was filed on 2 January 2026 (Purchase). Regulator: SEBI (PIT + SAST). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条